Skip to content

Retrospective Study of Patients With Spasticity in the Spanish Population

Observational Study To Establish The Methodology Used In The Evaluation, Treatment And Assessment Of Progression Of Spasticity In The Spanish Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01383681
Enrollment
235
Registered
2011-06-28
Start date
2011-02-28
Completion date
2012-10-31
Last updated
2013-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Spasticity

Brief summary

This is a retrospective study of patients with spasticity in the Spanish population.

Interventions

OTHERNo treatment

There was no treatment in this study.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of spasticity

Exclusion criteria

* Current enrollment in a clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Physician Assessment of SpasticityBaselineThe physician assessed spasticity as per local standard practice. Not enough data was collected for analysis of this outcome measure.

Countries

Spain

Participant flow

Pre-assignment details

This was a retrospective chart review in patients with spasticity in the Spanish population.

Participants by arm

ArmCount
All Participants
This was a retrospective chart review in patients with spasticity in the Spanish population. There was no treatment in this study.
235
Total235

Baseline characteristics

CharacteristicAll Participants
Age, Customized
18 to 25 years
21 Participants
Age, Customized
26 to 35 years
21 Participants
Age, Customized
36 to 45 years
43 Participants
Age, Customized
46 to 55 years
48 Participants
Age, Customized
56 to 65 years
57 Participants
Age, Customized
>65 years
45 Participants
Sex: Female, Male
Female
94 Participants
Sex: Female, Male
Male
141 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Physician Assessment of Spasticity

The physician assessed spasticity as per local standard practice. Not enough data was collected for analysis of this outcome measure.

Time frame: Baseline

Population: Planned analysis: All participants. Not enough data was collected for analysis of this outcome measure.

Primary

Physician Assessment of Spasticity

The physician assessed spasticity as per local standard practice. Not enough data was collected for analysis of this outcome measure.

Time frame: Month 12

Population: Planned analysis: All participants. Not enough data was collected for analysis of this outcome measure.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026